DAVID GRANOVSKY

US – ALS – ASC – BCLI

In ALL ARTICLES on August 25, 2009 at 8:22 am

— BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI | Quote | Chart | News | PowerRating) opened Monday at $0.084 per share on trading volume of 2,680,000 shares.

In a press release out on Aug 24, 2009 — BrainStorm Cell Therapeutics Inc. (OTCBB: BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that the company has secured the funding required to complete pre-clinical trials underway for the treatment of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease). The company expects to begin Phase I clinical studies in 2010.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: